公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2007 | Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study | CHIA-CHI LIN ; CHIH-HUNG HSU ; CHAO-YUAN HUANG ; Keng H.-Y.; YU-CHIEH TSAI ; KUO-HOW HUANG ; ANN-LII CHENG ; YEONG-SHIAU PU | Anti-Cancer Drugs | 32 | 29 | |
2011 | Gene polymorphisms of glutathione S-transferase omega 1 and 2, urinary arsenic methylation profile and urothelial carcinoma | Chung C.-J.; YEONG-SHIAU PU ; Su C.-T.; CHAO-YUAN HUANG ; Hsueh Y.-M. | Science of the Total Environment | 33 | 29 | |
2020 | Genetic analysis identifies the role of HLF in renal cell carcinoma | CHAO-YUAN HUANG ; HUANG S.-P.; HSUEH Y.-M.; CHEN L.-C.; LU T.-L.; BAO B.-Y. | Cancer Genomics and Proteomics | 6 | 6 | |
2022 | Genetic Analysis Implicates Dysregulation of SHANK2 in Renal Cell Carcinoma Progression | Chang, Chi-Fen; Huang, Shu-Pin; Hsueh, Yu-Mei; Geng, Jiun-Hung; CHAO-YUAN HUANG ; Bao, Bo-Ying | International journal of environmental research and public health | 1 | 0 | |
2020 | Genetic analysis reveals a significant contribution of ces1 to prostate cancer progression in taiwanese men | Ke C.-C.; Chen L.-C.; Yu C.-C.; Cheng W.-C.; CHAO-YUAN HUANG ; Lin V.C.; Lu T.-L.; Huang S.-P.; Bao B.-Y. | Cancers | 8 | 9 | |
2022 | Genetic Analysis Reveals the Prognostic Significance of the DNA Mismatch Repair Gene MSH2 in Advanced Prostate Cancer | Chang, Hao-Han; Lee, Cheng-Hsueh; Chen, Yei-Tsung; CHAO-YUAN HUANG ; Yu, Chia-Cheng; Lin, Victor C; Geng, Jiun-Hung; Lu, Te-Ling; Huang, Shu-Pin; Bao, Bo-Ying | Cancers | 5 | 7 | |
2020 | Genetic association analysis identifies a role for ANO5 in prostate cancer progression | Yu C.-C.; Chen L.-C.; CHAO-YUAN HUANG ; Lin V.C.; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. | Cancer Medicine | 10 | 9 | |
2015 | Genetic interaction analysis of TCF7L2 for biochemical recurrence after radical prostatectomy in localized prostate cancer | Chen C.-S.; CHAO-YUAN HUANG ; Huang S.-P.; Lin V.C.; Yu C.-C.; Chang T.-Y.; Bao B.-Y. | International Journal of Medical Sciences | 11 | 10 | |
2023 | Genetic Investigation of the Origin of an Allograft Ureteral Carcinoma with Short Tandem Repeats: From Recipient or Donor? | Sheu, Jia Yuh; SHIH-CHIEH CHUEH ; CHAO-YUAN HUANG ; HSIAO-LIN HWA ; SHUO-MENG WANG | Urological Science | | | |
2012 | Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy | Huang C.-N.; Huang S.-P.; Pao J.-B.; Hour T.-C.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Wu P.-P.; CHAO-YUAN HUANG ; Hsieh C.-J.; Bao B.-Y. | Journal of Internal Medicine | 32 | 31 | |
2012 | Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy | Huang S.-P.; Bao B.-Y.; Hour T.-C.; CHAO-YUAN HUANG ; Yu C.-C.; Liu C.-C.; Lee Y.-C.; Huang C.-N.; Pao J.-B.; Huang C.-H. | PLoS ONE | 16 | 29 | |
2021 | Genetic variants in MAPK10 modify renal cell carcinoma susceptibility and clinical outcomes | Tsai Y.-C.; CHAO-YUAN HUANG ; Hsueh Y.-M.; Fan Y.-C.; Fong Y.-C.; Huang S.-P.; Geng J.-H.; Chen L.-C.; Lu T.-L.; Bao B.-Y. | Life Sciences | 5 | 5 | |
2014 | Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer | Huang S.-P.; Levesque E.; Guillemette C.; Yu C.-C.; CHAO-YUAN HUANG ; Lin V.C.; Chung I.-C.; Chen L.-C.; Laverdi?re I.; Lacombe L.; Fradet Y.; Chang T.-Y.; Lee H.-Z.; Juang S.-H.; Bao B.-Y. | International Journal of Cancer | 40 | 34 | |
2013 | Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients | Huang S.-P.; Lin V.C.; Lee Y.-C.; Yu C.-C.; CHAO-YUAN HUANG ; Chang T.-Y.; Lee H.-Z.; Juang S.-H.; Lu T.-L.; Bao B.-Y. | European Journal of Cancer | 19 | 20 | |
2019 | Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression | Yu C.-C.; Chen L.-C.; Chiou C.-Y.; Chang Y.-J.; Lin V.C.; CHAO-YUAN HUANG ; Lin I.-L.; Chang T.-Y.; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. | Cancer Cell International | 15 | 13 | |
2015 | Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer | CHAO-YUAN HUANG ; Huang S.-P.; Lin V.C.; Yu C.-C.; Chang T.-Y.; Juang S.-H.; Bao B.-Y. | Scientific Reports | 20 | 17 | |
2016 | Genetic variants in ultraconserved regions associate with prostate cancer recurrence and survival | Bao B.-Y.; Lin V.C.; Yu C.-C.; Yin H.-L.; Chang T.-Y.; Lu T.-L.; Lee H.-Z.; Pao J.-B.; CHAO-YUAN HUANG ; Huang S.-P. | Scientific Reports | 18 | 19 | |
2015 | Genetic variants of the autophagy pathway as prognostic indicators for prostate cancer | CHAO-YUAN HUANG ; Huang S.-P.; Lin V.C.; Yu C.-C.; Chang T.-Y.; Lu T.-L.; Chiang H.-C.; Bao B.-Y. | Scientific Reports | 28 | 23 | |
2014 | Genetic variations in TP53 binding sites are predictors of clinical outcomes in prostate cancer patients | Lin V.C.; CHAO-YUAN HUANG ; Lee Y.-C.; Yu C.-C.; Chang T.-Y.; Lu T.-L.; Huang S.-P.; Bao B.-Y. | Archives of Toxicology | 12 | 11 | |
2021 | Genomic characterization of clear cell renal cell carcinoma using targeted gene sequencing | LIN P.-H.; CHAO-YUAN HUANG ; YU K.-J.; KAN H.-C.; LIU C.-Y.; CHUANG C.-K.; YU-CHUAN LU ; CHANG Y.-H.; SHAO I.H.; PANG S.-T. | Oncology Letters | 6 | 6 | |